The Cyclin Dependent Like Kinase 5 pipeline drugs market research report outlays comprehensive information on the Cyclin Dependent Like Kinase 5 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses the drugs in the Cyclin Dependent Like Kinase 5 pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline. Buy the report here.
The report also covers products from therapy areas such as Central Nervous System, and Oncology which include the indications Neurodegenerative Diseases, Alzheimer’s Disease, Colorectal Cancer, and Multiple Myeloma (Kahler Disease). It also reviews key players involved in Cyclin Dependent Like Kinase 5 targeted therapeutics development with respective active and dormant or discontinued products.
The Cyclin Dependent Like Kinase 5 pipeline targets constitutes close to six molecules. Out of which, approximately five molecules are developed by companies and the remaining by the universities/institutes. The molecules developed by companies in Phase I, Preclinical, and Discovery stages are 1, 1, and 3 respectively. Similarly, the universities portfolio in Preclinical comprises 1 molecule.
Cyclin Dependent Like Kinase 5 overview
Cell division protein kinase 5 is an enzyme encoded by the CDK5 gene. It does not directly control cell cycle regulation. Instead it functions in diverse processes such as synaptic plasticity and neuronal migration through phosphorylation of proteins required for cytoskeletal organization, endocytosis and exocytosis, and apoptosis. Dysregulation of this enzyme is involved in several neurodegenerative diseases including Alzheimer’s disease and invasive cancers.
For a complete picture of Cyclin Dependent Like Kinase 5’s drug pipeline, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.